Status:
UNKNOWN
Monocyte Soluble Activation Markers sCD14 and sCD163 in Children With Type 1 Diabetes Mellitus
Lead Sponsor:
Assiut University
Conditions:
Type1diabetes
Eligibility:
All Genders
5-18 years
Brief Summary
The study aims to compare serum levels of sCD14 and sCD163 in children with type 1 Diabetes Mellitus with healthy controls, study the distribution of monocyte subsets in children with T1DM , correlate...
Detailed Description
Type 1 diabetes mellitus (T1DM) is T-cell mediated autoimmune disease in which the function of insulin-secreting pancreatic β-cells is impaired due to autoreactive immune cell-mediated destruction (in...
Eligibility Criteria
Inclusion
- Children of any age and sex diagnosed with T1DM (according to WHO criteria) with a minimum duration of five years will be included.
Exclusion
- Children with other with coexisting autoimmune, chronic, and acute inflammatory diseases.
Key Trial Info
Start Date :
July 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 1 2023
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT05347836
Start Date
July 1 2022
End Date
August 1 2023
Last Update
April 26 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.